Presymptomatic Detection and Intervention for Autism Spectrum Disorder

Area of Science:

• Neurodevelopmental disorders
• Pediatric medicine
• Bioethics

Background:

• Universal screening for autism spectrum disorder (ASD) is recommended by age two, but many children are diagnosed later.
• Objective measures for early ASD risk detection in infancy are under development.
• MRI-based screening shows promise for high-risk infants but requires clinical trials.

Purpose of the Study:

• To present a hypothetical clinical trial design for presymptomatic ASD detection and intervention.
• To explore ethical issues associated with early ASD detection and intervention through diverse expert commentaries.
• To consider the social value, clinical potential, challenges, and risks/benefits of such research.

Main Methods:

• The study outlines a hypothetical clinical trial design.
• It incorporates commentaries from experts in bioethics, clinical practice, and neurodiversity.
• Ethical considerations, risks, and benefits are evaluated from multiple perspectives.

Main Results:

• The abstract does not present results, as it focuses on study design and ethical considerations.
• Commentaries highlight the social value and clinical potential of presymptomatic ASD research.
• Ethical challenges, neurodiversity implications, and risk-benefit analyses are discussed.

Conclusions:

• Further research and clinical trials are needed for presymptomatic ASD detection and intervention.
• Anticipating and addressing ethical issues is paramount for responsible research.
• Balancing potential benefits with risks is essential for future phases of ASD research.